Roper’s Strategic Shift Drives 1.85% Stock Rally on $760M Volume Surge, 149th in U.S. Equity Trading Rankings

Roper (ROP) saw its shares rise 1.85% on October 8, 2025, with a trading volume of $760 million—a 47.2% increase from the previous day—ranking 149th in volume among U.S. equities. The surge followed a strategic shift in its medical diagnostics segment, which announced a partnership to expand point-of-care testing solutions for hospitals. Analysts noted the move could enhance Roper’s market share in the $4.3 billion rapid diagnostics sector, where demand remains elevated due to ongoing supply chain constraints in lab testing services.

Recent earnings reports highlighted stable performance in Roper’s industrial automation division, which offset slower growth in its cybersecurity unit. The company’s decision to reallocate capital toward high-margin diagnostic projects was cited as a key driver of investor confidence. Separately, regulatory filings revealed no material changes to its debt structure, countering speculative sell-offs in prior weeks.

To run this back-test accurately I need to lock down a few practical details: 1. Universe—All U.S. exchange-listed common stocks (NYSE + NASDAQ)? Or a specific index membership (e.g., Russell 3000 constituents)? 2. Ranking & execution timing—Rank stocks by that day’s trading volume, then: Buy the 500 highest-volume names at the close of the same day and sell them at the next day’s close (T + 1)? Or buy at the next day’s open and sell at that day’s close? 3. Weighting—Equal-weight each of the 500 positions for the one-day hold? Once we firm up these points I can generate the daily portfolios and feed them into the back-test engine.